- Presentations
- 3
- Markets
- 1
Myrbetriq is a brand of Mirabegron marketed by Astellas Pharma, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mirabegron
- Brand owner
- Astellas Pharma
- Registered in
- United States
- Strengths and forms
- 8 mg/mL extended-release oral suspension, 25 mg extended-release tablet, 50 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Myrbetriq 8 mg/mL extended-release oral suspensionOral | Astellas Pharma | US FDA | Available on request |
| Myrbetriq 25 mg extended-release tabletOral | Astellas Pharma | US FDA | Available on request |
| Myrbetriq 50 mg extended-release tabletOral | Astellas Pharma | US FDA | Available on request |
Equivalent brands
Other brands of Mirabegron.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Myrbetriq
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.